Have a personal or library account? Click to login
Akkermansia Muciniphila is Associated with Human Health: What Should we Know? Cover

Akkermansia Muciniphila is Associated with Human Health: What Should we Know?

Open Access
|Sep 2025

References

  1. Anhê F, Marette A. A microbial protein that alleviates metabolic syndrome. Nat Med. 2017 Jan; 6:23(1):11-12. https://doi.org/10.1038/nm.4261
  2. Azad MB, Kozyrskyj AL. CHILD Study Investigators. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013 Mar; 19:185(5):385-94. https://doi.org/10.1503/cmaj.121189
  3. Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, de Vos WM. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio. 2017 Sep; 19:8(5):e00770-17. https://doi.org/10.1128/mBio.00770-17
  4. Bian X, Wu W, Yang L, Lv L, Wang Q, Li Y, Ye J, Fang D, Wu J, Jiang X, et al. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Front Microbiol. 2019 Oct; 1:10:2259. https://doi.org/10.3389/fmicb.2019.02259
  5. Cozzolino A, Vergalito F, Tremonte P, Iorizzo M, Lombardi SJ, Sorrentino E, Luongo D, Coppola R, Di Marco R. Succi M. Preliminary evaluation of the safety and probiotic potential of Akkermansia muciniphila DSM 22959 in comparison with Lactobacillus rhamnosus GG. Microorganisms. 2020 Jan; 30:8(2):189 https://doi.org/10.3390/microorganisms8020189
  6. Daniel N, Gewirtz AT, Chassaing B. Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism. Gut. 2023 May; 72(5):906-917. https://doi.org/10.1136/gutjnl-2021-326835
  7. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004 Sep; 54(Pt 5):1469-1476. https://doi.org/10.1099/ijs.0.02873-0
  8. Druart C, Plovier H, Van Hul M, Brient A, Phipps KR, de Vos WM, Cani PD. Toxicological safety evaluation of pasteurized Akkermansia muciniphila. J Appl Toxicol. 2021 Feb; 41(2):276-290. https://doi.org/10.1002/jat.4044
  9. Earley H, Lennon G, Balfe Á, Coffey JC, Winter DC, O’Connell PR. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis. Sci Rep. 2019 Oct; 30:9(1):15683. https://doi.org/10.1038/s41598-019-51878-3
  10. Geerlings SY, Kostopoulos I, de Vos WM, Belzer C. Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how? Microorganisms. 2018 Jul; 23:6(3):75. https://doi.org/10.3390/microorganisms6030075
  11. Glover JS, Ticer TD, Engevik MA. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci Rep. 2022 May; 19:12(1):8456. https://doi.org/10.1038/s41598-022-11819-z
  12. Greer RL, Dong X, Moraes AC, Zielke RA, Fernandes GR, Peremyslova E, Vasquez-Perez S, Schoenborn AA, Gomes EP, Pereira AC, et al. Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nat Commun. 2016 Nov; 14:7:13329. https://doi.org/10.1038/ncomms13329
  13. Grześkowiak Ł, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe. 2012 Feb; 18(1):7-13. https://doi.org/10.1016/j.anaerobe.2011.09.006
  14. Guo X, Zhang J, Wu F, Zhang M, Yi M, Peng Y. Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China. J Appl Microbiol. 2016 Feb; 120(2):452-9. https://doi.org/10.1111/jam.13022
  15. Kobayashi Y, Kawahara T, Inoue S, Kohda N. Akkermansia biwaensis sp. nov., an anaerobic mucin-degrading bacterium isolated from human faeces. Int J Syst Evol Microbiol. 2023 Feb; 73(1). https://doi.org/10.1099/ijsem.0.005697
  16. Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe-/- Mice. Circulation. 2016 Jun; 14:133(24):2434-46. https://doi.org/10.1161/CIRCULATION-AHA.115.019645
  17. Meng X, Xv C, Lv J, Zhang S, Ma C, Pang X. Optimizing Akkermansia muciniphila Isolation and Cultivation: Insights into Gut Microbiota Composition and Potential Growth Promoters in a Chinese Cohort. Microorganisms. 2024 Apr; 28:12(5):881. https://doi.org/10.3390/microorganisms12050881
  18. Zhang MX, Wu J, Zhao LP, Zhao WJ, Cui C, Shen YQ. Akkermansia muciniphila is beneficial to a mouse model of parkinson’s disease, via alleviated neuroinflammation and promoted neurogenesis, with involvement of SCFAs. Brain Sci. 2024 Feb; 29:14(3):238. https://doi.org/10.3390/brainsci14030238
  19. Qingsen S, Guanrui S, Meifang Z, Jingjing S, Cuiying X, Jiejie H, Guoyun L, Guangli Y. Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice. J Funct Foods. 2017 Nov; 28:136-146. https://doi.org/10.1016/j.jff.2016.11.002.
  20. Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Akkermansia muciniphila alleviates dextran sulfate sodium (DSS)-induced acute colitis by NLRP3 activation. Microbiol Spectr. Microbiol Spectr. 2021 Oct; 31:9(2):e0073021.https://doi.org/10.1128/Spec-trum.00730-21
  21. Roopchand DE, Carmody RN, Kuhn P, Moskal K, Rojas-Silva P, Turnbaugh PJ, Raskin I. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes. 2015 Aug; 64(8):2847– 2858. https://doi.org/10.2337/db14-1916
  22. Si J, Kang H, You HJ, Ko G. Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. Gut Microbes. 2022 Jan-Dec; 14(1):2078619. https://doi.org/10.1080/19490976.2022.2078619
  23. Song C, Chai Z, Chen S, Zhang H, Zhang X, Zhou Y. Intestinal mucus components and secretion mechanisms: what we do and do not know. Exp Mol Med. 2023 Apr; 55(4):681-691. https://doi.org/10.1038/s12276-023-00960-y
  24. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug; 6:8(8):e70803.https://doi.org/10.1371/journal.pone.0070803
  25. Wu H, Qi S, Yang R, Pan Q, Lu Y, Yao C, He N, Huang S, Ling X. Strategies for high cell density cultivation of Akkermansia muciniphila and its potential metabolism. Microbiol Spectr. 2024 Jan; 11:12(1):e0238623. https://doi.org/10.1128/spectrum.02386-23
  26. Wu X, Yu D, Ma Y, Fang X, Sun P. Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review. Int J Biol Macromol. 2025 May; 308(Pt 4):142442. https://doi.org/10.1016/j.ijbiomac.2025.142442
  27. Yilmaz O, Okullu SO, Catakci M, Elmas MA, Pinheiro Y, Arbak S, Demir E, Schaefer KH, Kolgazi M. Akkermansia muciniphila improves chronic colitis-induced enteric neuroinflammation in mice. Neurogastroenterol Motil. 2024 Mar; 36(3):e14745. https://doi.org/10.1111/nmo.14745
  28. Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C. Strain-specific anti-inflammatory properties of two Akkermansia muciniphila strains on chronic colitis in mice. Front Cell Infect Microbiol. 2019 Jul; 5:9:239. https://doi.org/10.3389/fcimb.2019.00239
  29. Zhang T, Li P, Wu X, Lu G, Marcella C, Ji X, Ji G, Zhang F. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation. Appl Microbiol Biotechnol. 2020 Dec; 104(23):10203-10215. https://doi.org/10.1007/s00253-020-10948-7
  30. Zhang Y, Liu R, Chen Y, Cao Z, Liu C, Bao R, Wang Y, Huang S, Pan S, Qin L, et al. Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut. Cell Metab. 2025 Mar; 4:37(3):592-605.e6. https://doi.org/10.1016/j.cmet.2024.12.010
  31. Zhou Q, Zhang Y, Wang X, Yang R, Zhu X, Zhang Y, Chen C, Yuan H, Yang Z, Sun L. Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project. Nutr Metab (Lond). 2020 Oct; 22:17:90. https://doi.org/10.1186/s12986-020-00516-1
DOI: https://doi.org/10.2478/am-2025-0011 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 141 - 146
Submitted on: Apr 29, 2025
Accepted on: Jul 23, 2025
Published on: Sep 30, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Bartosz Ostrowski, Beata Krawczyk, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.